ABSTRACT
Objectives Worldwide, peripheral arterial disease (PAD) is a disorder with high morbidity, affecting more than 200 million people. Our objective was to analyse the surgical treatment for PAD performed in the Unified Health System of Brazil over 12 years based on publicly available data.
Methods The study was conducted with data analysis available on the DATASUS platform of the Brazilian Health Ministry, assessing procedure technique distribution throughout the years, mortality and cost.
Results A total of 129,424 procedures were analysed (either for claudicants or critical ischemia, proportion unknown). The vast majority of procedures were Endovascular (65.49%), with a tendency for increase in this disproportion (p<0.001). There were 3,306 in-hospital deaths (mortality of 2.55%), with lower mortality in the Endovascular group (1.2% vs. 5.0%, p=0.008). The overall governmental investment for these procedures was U$ 238,010,096.51, and Endovascular Procedures were on average significantly more expensive than Open Surgery (U$ 1,932.27 v. U$ 1,517.32; p=0.016).
Conclusions In the Brazilian Public Health System, lower limb revascularizations occurred with gradual growing frequency between 2008 and 2019. Endovascular procedures were vastly more common, and related to lower in-hospital mortality rates, but higher procedural costs.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All information was extracted from the DATASUS portal, which is a digital platform though which the Brazilian government provides open data relating to procedures performed under the Public Health System in adequately accredited hospitals. Institutional accreditation in the system is prerequisite for receiving governmental payment for the procedures performed. All data is appropriately de-identified. DATASUS can be accessed at: https://datasus.saude.gov.br/informacoes-de-saude-tabnet/ This study was submitted to our institutional review board at the Hospital Israelita Albert Einstein (protocol number 4324-20). Since all data was anonymous, a waiver of Informed Consent was requested and granted. Study was approved by the Hospital Israelita Albert Einstein Ethics Committee under protocol 35826320.2.0000.0071 by Technical Statement 4.321.508, issued on the 6th of October, 2020.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Paper conception, manuscript composition, critical revision, manuscript acceptance, agreement to accountability.
Paper conception, data collection, manuscript acceptance, agreement to accountability.
Manuscript composition, critical revision, manuscript acceptance, agreement to accountability.
Data collection, manuscript acceptance, agreement to accountability.
Paper conception, critical revision, manuscript acceptance, agreement to accountability.
Faculdade de Ciências Médicas da Santa Casa de São Paulo, Rua Dr. Cesário Motta Jr., 61. ZIP: 01221-020, São Paulo, SP – Brazil.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
